Efficacy of infliximab in long-lasting refractory Kawasaki disease

Clin Exp Rheumatol. Jul-Aug 2006;24(4):453.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Aspirin / therapeutic use
  • Child, Preschool
  • Drug Resistance
  • Drug Therapy, Combination
  • Humans
  • Infliximab
  • Injections, Intravenous
  • Male
  • Mucocutaneous Lymph Node Syndrome / drug therapy*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / therapeutic use*
  • Warfarin / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Warfarin
  • Infliximab
  • Aspirin